South Annual Conference

Location: Fort Lauderdale, FL
Date: February 6-9, 2014

Meeting Overview

Venue:
Broward County Convention Center
Primary Audience:
Primary Care
Credits:
Refer to the Accreditation Tab

Thank you to the 4,260 Primary Care Clinicians that joined us at Pri-Med South.


For those who look to you—you can look to us.

Primary care is where good health begins. It is based on your relationship with your patients as you provide and coordinate the care they need, from preventive health to specialty care to inpatient services. The demands and challenges you face every day within your practice are constantly changing, so we’re changing with you.

We’ve taken the feedback of clinicians in your region and across the country to launch an all-new Annual Conference.

Pri‑Med has expanded its partnership with the American College of Physicians (ACP), and in collaboration with the ACP we will be unveiling an entirely new cutting-edge CME curriculum. The CME sessions will include the latest treatments and therapies, such as:

  • Live Demonstration Orthopedic Exam: See It, Do It
  • Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
  • Lung Sounds: A Primer on Pulmonary Auscultation

View the full session schedule »

But that’s not all…

In addition to over 35 new educational sessions, there are many new components of the conference that were created with you in mind.

  • Join us on Friday night for an Opening Night Reception with complimentary cocktails and hors d’oeuvres
  • SAFE Opioid Prescribing certification sessions featuring a faculty meet and greet and book signing
  • Three renowned Keynote Speakers including Dr. Michael Dansinger, a weight loss and nutrition consultant for NBC’s “The Biggest Loser” and Dr. Story Musgrave, former NASA astronaut and part-time trauma surgeon.

Keynote speaker sneak peeks »

Earn up to 27.25 AMA PRA Category 1 Credits™, 27.25 AAFP Prescribed Credits, or 27.25 AANP contact hours of continuing education by attending all 4 days.

Register Today

Register for Pri‑Med South by: Your price**
October 17 $30
December 5 $40
January 16 $55
February 2 $75
Onsite at Pri‑Med South $100

*Primary Care Updates tracks are sponsored by pmiCME and are produced independently of and are not affiliated with the American College of Physicians. This is a limited-capacity ticketed event available on a first-come, first-served basis and by registration.

**Price represents online registration; registration by phone is an additional $10.

Good Health Begins Here

Opening Night Reception
As a simple thank-you for all you do, please join us for complimentary cocktails and hors d’oeuvres on Friday night.


Comprehensive CME Program

Primary Care Updates*
February 6, 2014
A multi-track day of CME programs to supplement your education. Earn up to 8.25 AMA PRA Category 1 Credits™ or 8.25 AANP contact hours of continuing education.

Annual Conference
February 7–9, 2014
An entirely new cutting-edge CME curriculum developed in collaboration with the American College of Physicians. Earn up to 19 AMA PRA Category 1 Credits™ or 19 AANP contact hours of continuing education.


Educational Symposia
Accredited CME sessions to expand your learning during breaks from the core ACP curriculum.


Industry-sponsored Opportunities

Exhibit Hall
Have face-to-face conversations with industry professionals, gain helpful takeaways, and experience engaging floor activities such as live demonstrations, outside your office hours. Learn More »

Presentation Theaters
Live discussions led by prominent medical thought leaders. Get an in-depth look at the latest tools and treatment options.


Distribution of all additional opportunity tickets will happen on-site on a first-come, first-served basis at the Ticket Booth. Please check-in early to ensure tickets are available for the additional opportunities you want to participate in.

Presentation Theaters are not offered for CME credit nor is the content planned or reviewed by pmiCME or ACP.

Pri-Med South Mobile App

Sessions & Syllabus

For your convenience, we have printer-friendly syllabus slides available for you to download.

Print Primary Care Updates Syllabus

CLOSE  X  
Registration & Breakfast
CLOSE  X  
Registration & Breakfast
CLOSE  X  
Opening Remarks
CLOSE  X  
Opening Remarks
CLOSE  X  
The Role of Non-Invasive Cardiac Imaging in Primary Care: When and How To Use It
Room: Grand Floridian D, Level 3
Learning Objectives:
  1. Identify patients who are appropriate candidates for non-invasive cardiac imaging and cardiology referral.
  2. Recognize current guideline recommended indications for non-invasive cardiac imaging tests and apply them in the selection of appropriate tests for CV risk assessment.
  3. Describe the value and limitations of various non-invasive cardiac imaging techniques for cardiovascular risk stratification in patients with known or suspected coronary artery disease.
  4. Outline the differences between the pharmacologic stress agents used in conjunction with non-invasive cardiac imaging.
Faculty:
  1. Prem Soman, MD, PhD, FRCP, Associate Professor of Medicine (Cardiology), Director, Nuclear Cardiology Labs, Director, Advanced Cardiac Imaging Fellowship Program, UPMC Heart and Vascular InstitutePittsburgh, PA (Bio)
  2. Saurabh Malhotra, MD, MPH, Clinical Instructor, UPMC Heart and Vascular InstitutePittsburgh, PA (Bio)
CLOSE  X  
Keeping Adult Patients Healthy: The Role of Adult Immunization
Room: Floridian Ballroom, Level 3
Learning Objectives:
  1. Identify adult patients for appropriateness of administering vaccines based on current recommendations.
  2. Act to increase provider recommendations to patients who should be vaccinated.
  3. Implement standing orders for adult immunization within practice settings.
Faculty:
  1. Robert Hopkins, MD, FACP, FAAP, Professor of Internal Medicine and Pediatrics, University of Arkansas for Medical Sciences College of MedicineLittle Rock, AR
  2. M. Susan Burke, MD, FACP, Clinical Assistant Professor of Medicine, Thomas Jefferson UniversityPhiladelphia, PA (Bio)
CLOSE  X  
AM Break
CLOSE  X  
AM Break
CLOSE  X  
Five Things to Do Differently for Your Patients with Depression: Working Toward Successful Treatment
Room: Floridian Ballroom, Level 3
Learning Objectives:
  1. Describe serotonergic pathways, including the benefits of specific therapeutic modulation of monoamine neurotransmission.
  2. Implement comprehensive antidepressant treatment strategies, incorporating both pharmacotherapy and psychotherapy, with the goal of sustained remission.
  3. Utilize antidepressants effectively based on their mechanism of action (MOA), onset of action, safety profile, and patient needs.
  4. Communicate effectively to patients the importance of adhering to medications and expectations of treatment.
Faculty:
  1. Vladimir Maletic, MD, MS, Clinical Professor of Neuropsychiatry and Behavioral Science, University of South Carolina School of MedicineColumbia, SC, Consulting Associate, Division of Child and Adolescent Psychiatry, Department of Psychiatry, Duke UniversityDurham, NC
  2. Charles Raison, MD, Associate Professor, Department of Psychiatry, College of Medicine, John and Doris Norton School of Family and Consumer Sciences, University of ArizonaTucson, AZ
CLOSE  X  
Against All Odds: Improving Insulin Use in T2DM through Individualized Clinical Decision Making
Room: Grand Floridian D, Level 3
Learning Objectives:
  1. Summarize the clinical evidence supporting the use of basal insulin therapy, with and without GLP-1 receptor agonists, in the management of type 2 diabetes.
  2. Incorporate strategies to overcome barriers to insulin use in the treatment of type 2 diabetes.
Faculty:
  1. Frank Lavernia, MD, Founder, North Broward Diabetes CenterPompano Beach, FL (Bio)
  2. Paul Jellinger, MD, Professor of Clinical Medicine, University of Miami Coral Gables, FL, Past President, American College of Endocrinology, Past President, American Association of Clinical EndocrinologistsJacksonville, FL
  3. Richard Pratley, MD, Chair in Diabetes Research, Director, Florida Hospital Diabetes Institute, Samuel E. CrockettFL, Senior Scientist, Translational Research Institute for Metabolism and DiabetesOrlando, FL, Professor, Sanford Burnham Medical Research InstituteOrlando, FL (Bio)
CLOSE  X  
Incorporating GLP-1 Receptor Agonist Therapy in T2DM Management: Achieving a Comfort Zone in 2014
Room: Floridian Ballroom, Level 3
Learning Objectives:
  1. Implement treatment regimens for patients with type 2 diabetes in accordance with recently updated treatment recommendations.
  2. Review the clinical evidence for the use of incretin-based therapies in type 2 diabetes management.
Faculty:
  1. Javier Morales, MD, St. Francis Hospital, Vice President, Principal Clinical Trials Investigator, Advanced Internal Medicine Group, PCGreat Neck, NY (Bio)
  2. Jack Leahy, MD, Professor of Medicine, Chief, Division of Endocrinology, Diabetes and Metabolism, University of Vermont College of MedicineBurlington, VT (Bio)
  3. Jeff Unger, MD, FACE , ABFM, Assistant Professor of Family Medicine, Loma Linda University School of MedicineRiverside, CA, Medical Director, The Unger Primary Care Medical CenterChino, CA, Associate Director of Metabolic Studies, Catalina Research InstituteChino, CA
CLOSE  X  
Chronic Obstructive Pulmonary Disease - Practical Approaches to Diagnosis and Management
Room: Grand Floridian D, Level 3
Learning Objectives:
  1. Evaluate the role of spirometry in COPD diagnosis and monitoring.
  2. Review recommended pharmacologic interventions to reduce COPD symptoms and decrease exacerbations.
  3. Select appropriate patient counseling strategies.
Faculty:
  1. Barbara Yawn, MD, MSc, FAAFP, Director of Research, Olmsted Medical Center Rochester, MN, Adjunct Professor, Department of Family and Community Health, University of MinnesotaMinneapolis, MN
  2. Fernando Martinez, MD, MS, Professor, Department of Internal Medicine, Associate Chief for Clinical Research, Division of Pulmonary Diagnostic Services, Director, Pulmonary Diagnostic Services, University of Michigan Health SystemAnn Arbor, MI
CLOSE  X  
Lunch
CLOSE  X  
Lunch
CLOSE  X  
Tools for Diagnosis, Assessment, and Management of Chronic Obstructive Pulmonary Disease in Clinical Practice
Room: Floridian Ballroom, Level 3
Learning Objectives:
  1. Utilize recommendations, such as those of GOLD and the COPD Foundation, for the diagnosis of COPD, including the use of spirometry and evaluation of symptoms.
  2. Evaluate and differentiate between standard COPD therapies for decreasing exacerbations and improving symptoms and other outcomes.
  3. Integrate recently approved agents into the COPD treatment armamentarium through evidence based decision-making.
Faculty:
  1. Jill Ohar, MD, Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine, Center for Genomics and Personalized Medicine Research, Comprehensive Cancer Center, Center for Worker Health, Director for Respiratory Therapy, Wake Forest Baptist HealthWinston-Salem, NC
  2. Fernando Martinez, MD, MS, Professor, Department of Internal Medicine, Director, Pulmonary Diagnostic Services, University of MichiganAnn Arbor, MI
CLOSE  X  
Improving Outcomes for Acute Coronary Syndrome Patients: Best Practices for Primary Care Clinicians
Room: Grand Floridian D, Level 3
Learning Objectives:
  1. Summarize fundamental similarities and differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics of oral antiplatelet drugs.
  2. Explain efficacy and safety data with oral antiplatelet therapies from ACS outcomes trials.
  3. Recognize guideline-based therapies to reduce risk and goals to achieve in the management of patients who have experienced an acute coronary syndrome.
Faculty:
  1. Jeffrey Berger, MD, MS, Assistant Professor of Medicine, New York University School of MedicineNew York, NY
  2. Jessica Mega, MD , MPH, Assistant Professor of Medicine, Harvard Medical SchoolBoston, MA
CLOSE  X  
PM Break
CLOSE  X  
Managing the Patient with High Triglycerides: Assessment and Treatment Strategies
Room: Floridian Ballroom, Level 3
Learning Objectives:
  1. Discuss the role of elevated triglyceride levels in the assessment and diagnosis of dyslipidemia, including cardiovascular risk factors.
  2. Apply best practices in the attainment of TG levels, including the role of fasting and non-fasting states in accurate evaluation.
  3. Evaluate the management of hypertriglyceridemia through greater adherence to evidenced based practices and accepted guidelines.
  4. Select potential new and emerging therapeutic approaches to manage TG-based dyslipidemia, mixed dyslipidemia, and associated cardiovascular risk.
Faculty:
  1. Harold Bays, MD, FACP, FACE, Medical Director, President, Louisville Metabolic and Atherosclerosis Research Center (L-MARC)Louisville, KY (Bio)
  2. Michael Miller, FACC , MD , FAHA, Professor, Departments of Medicine, Epidemiology & Public Health, University of Maryland School of MedicineBaltimore, MD, Director, Center for Preventive Cardiology, University of Maryland Medical CenterBaltimore, MD
CLOSE  X  
PM Break
CLOSE  X  
Working Against the Clock: Practical Strategies for Diagnosis and Management of Shift Work Disorder
Room: Grand Floridian D, Level 3
Learning Objectives:
  1. Describe the pathophysiologic basis of circadian rhythm misalignment and its relationship to sleep/wakefulness and overall health.
  2. Establish the differential diagnosis of SWD based on symptomatology, patient history, and findings obtained from a thorough sleep history and other assessment tools.
  3. Formulate evidence-based initial and ongoing treatment plans for SWD that incorporate nonpharmacologic and pharmacologic modalities.
Faculty:
  1. Paul Doghramji, FAAFP , MD, Attending Physician, Collegeville Family PracticeCollegeville, PA, Medical Director of Health Services, Ursinus CollegeCollegeville, PA (Bio)
  2. Christopher Drake, PhD, Bioscientific Staff, Sleep Disorders and Research Center, Henry Ford HospitalDetroit, MI, Associate Professor, Psychiatry and Behavioral Neuroscience, Wayne State University School of MedicineDetroit, MI (Bio)
CLOSE  X  
Concussion 2014: An Update
Room: Floridian Ballroom, Level 3
Learning Objectives:
  1. Differentiate concussion presentation from other forms of traumatic brain injury
  2. Implement the latest guidelines for managing the concussion patient including recommendations for returning back to work or sports
Faculty:
  1. Adam Chrusch, MD, Adjunct Assistant Clinical Professor of Family and Community Medicine, Drexel University College of MedicinePhiladelphia, PA, Adjunct Assistant Clinical Professor of Family and Community Medicine, Temple University School of MedicinePhiladelphia, PA, Assistant Program Director, Family Medicine Residency Program, Abington Memorial Hospital Abington, PA (Bio)
CLOSE  X  
Major Depression in the Primary Care Setting: Clinical Updates on Novel Strategies for Relapse Prevention and Sustained Recovery
Learning Objectives:
  1. Identify residual symptoms of MDD and evaluate their impact on symptomatic remission and recovery.
  2. Review recent clinical updates on traditional and newer pharmacotherapies for MDD and their benefits/limitations in symptomatic remission and recovery.
  3. Examine the role of serotonin in the pathogenesis of MDD, including the significance of molecular targets in mitigating residual symptoms of depression.
Faculty:
  1. Larry Culpepper, MD, MPH, Professor of Family Medicine, Boston University School of MedicineBoston, MA, Staff Physician, Boston Medical CenterBoston, MA (Bio)
  2. Bradley Gaynes, MD, MPH, Professor of Psychiatry, Associate Chair for Research Training and Education, University of North Carolina School of MedicineChapel Hill, NC (Bio)
Primary Care Updates Track 1
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: Merck & Co., Inc., Forest Laboratories, Inc., Novo Nordisk Inc. and Supported by an educational grant from Amarin Pharma, Inc.
Primary Care Updates Track 2
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: Astellas Pharma US, Inc, Novo Nordisk Inc., AstraZeneca, Teva CNS and Takeda Pharmaceuticals International, Inc., U.S. Region and Lundbeck Pharmaceutical Services, LLC.
6:45AM
 
7:15AM
 
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
3:15PM
 
3:45PM
 
4:15PM
 
4:45PM
 
6:45 AM-7:35 AM - Registration & Breakfast
6:45 AM-7:35 AM - Registration & Breakfast
  
  
7:35 AM-7:45 AM - Opening Remarks
7:35 AM-7:45 AM - Opening Remarks
7:45 AM-9:00 AM
Keeping Adult Patients Healthy: The Role of Adult Immunization
7:45 AM-9:15 AM
The Role of Non-Invasive Cardiac Imaging in Primary Care: When and How To Use It
  
  
  
  
9:00 AM-9:15 AM - AM Break
 
9:15 AM-10:45 AM
Five Things to Do Differently for Your Patients with Depression: Working Toward Successful Treatment
9:15 AM-9:30 AM - AM Break
 
9:30 AM-11:00 AM
Against All Odds: Improving Insulin Use in T2DM through Individualized Clinical Decision Making
  
  
  
  
10:45 AM-12:15 PM
Incorporating GLP-1 Receptor Agonist Therapy in T2DM Management: Achieving a Comfort Zone in 2014
 
 
11:00 AM-12:15 PM
Chronic Obstructive Pulmonary Disease - Practical Approaches to Diagnosis and Management
  
  
  
  
12:15 PM-1:00 PM - Lunch
12:15 PM-1:00 PM - Lunch
  
  
1:00 PM-2:15 PM
Tools for Diagnosis, Assessment, and Management of Chronic Obstructive Pulmonary Disease in Clinical Practice
1:00 PM-2:30 PM
Improving Outcomes for Acute Coronary Syndrome Patients: Best Practices for Primary Care Clinicians
  
  
  
  
2:15 PM-2:30 PM - PM Break
 
2:30 PM-3:45 PM
Managing the Patient with High Triglycerides: Assessment and Treatment Strategies
2:30 PM-2:45 PM - PM Break
 
2:45 PM-4:00 PM
Working Against the Clock: Practical Strategies for Diagnosis and Management of Shift Work Disorder
  
  
  
3:45 PM-5:15 PM
Concussion 2014: An Update
 
 
4:00 PM-5:15 PM
Major Depression in the Primary Care Setting: Clinical Updates on Novel Strategies for Relapse Prevention and Sustained Recovery
  
  
  
  
CLOSE  X  
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
Room: Hall D, Level 1
Getting your patients to lose weight is never easy. Learn in this keynote address from the weight loss and nutrition consultant to NBC's "The Biggest Loser" about effective lifestyle and behavioral approaches to achieve weight loss goals in your overweight and obese patients.
Learning Objectives:
  1. Employ proven, evidence-based lifestyle and behavioral modalities to help your obese patients lose weight and achieve health benefits.
Faculty:
  1. Michael Dansinger, MD, Director of the Diabetes Reversal Program, Tufts Medical CenterBoston, MA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Live Demonstration Orthopedic Exam: See It, Do it
Room: Hall D, Level 1
Learn orthopedic maneuvers to assess common office-based musculoskeletal complaints.
Learning Objectives:
  1. Through live demonstration of orthopedic maneuvers, you will improve your ability to diagnose common musculoskeletal complaints of the upper body, low back, hip, and knee.
Faculty:
  1. M. Susan Burke, MD, FACP, Clinical Assistant Professor of Medicine, Thomas Jefferson UniversityPhiladelphia, PA, Senior Advisor, Internal Medicine Clinical Care Center, Lankenau Medical CenterWynnewood, PA (Bio)
CLOSE  X  
Targeting Better Cardiac Outcomes for High-Risk Patients
Room: Floridian Ballroom, Level 3
This session will provide important update information on low HDL-C levels and elevated triglycerides as therapeutic targets to reduce cardiovascular disease risk.
Learning Objectives:
  1. Evaluate recent clinical trials with respect to management of low HDL.
  2. Examine the data on triglycerides and CVD risk to determine how aggressively to treat patients with elevated TGs.
  3. Employ strategies for reducing CVD risk in patients with type 2 diabetes and hypertension.
Faculty:
  1. Danielle Duffy, FACC, MD, Assistant Professor of Medicine, Division of Cardiology, Jefferson Medical CollegePhiladelphia, PA, Director, Cardiovascular Risk Reduction, Jefferson Heart InstitutePhiladelphia, PA (Bio)
CLOSE  X  
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
Room: Floridian Ballroom, Level 3
This session will provide new insight into the pathogenesis of dyslipidemia in the type 2 diabetic patient with chronic kidney disease and the rationale for advanced lipid testing (i.e., lipoprotein particle analysis) in these patients at high CV risk.
Learning Objectives:
  1. Describe the pathogenesis of dyslipidemias in patients with diabetes and chronic kidney disease.
  2. Understand the rationale for performing lipoprotein particle analysis in patients with high CV risk comorbidities.
Faculty:
  1. Matthew Sorrentino, FASH , MD, FACC, Professor of Medicine, Department of Medicine, Section of Cardiology, University of Chicago Pritzker School of MedicineChicago, IL, Specialist in Clinical Hypertension, American Society of HypertensionTX (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Engaging e-Patients: How e-Messaging, Personal Health Records, and Patient Activation Can Transform Your Practice
Room: Floridian Ballroom, Level 3
Participatory medicine is being driven by e-health technoloogy and represents a significant paradigm shift. Learn how e-messaging, patient health records/patient portals and online resources can and are improving patient care through improved communication between you and your patients.
Learning Objectives:
  1. Take advantage of online resources to expand your medical knowledge and augment your clinical expertise.
  2. Provide practical advice to patients about smart and appropriate use of web-based health information and social media.
Faculty:
  1. Daniel Sands, MD, MPH, Assistant Clinical Professor of Medicine, Harvard Medical SchoolBoston, MA, Attending Physician, Beth Israel Deaconess Medical CenterBoston, MA (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
Room: Hall D, Level 1
Practicing clinicians face the challenge of evaluating patients for aberrant drug behavior when prescribing opioid therapy for pain management. This session will help improve your ability to identify risk factors for drug-seeking behaviors and to differentiate between opioid tolerance, physical dependence and addiction.
Learning Objectives:
  1. Identify risk factors for opioid-related aberrant behavior.
  2. Differentiate between tolerance, physical dependence and addiction.
Faculty:
  1. Charles Argoff, MD, Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY
  2. Michael Brennan, MD, FACP, FASAM (Bio)
  3. Jeffrey Gudin, MD (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
SAFE Opioid Prescribing: Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
Room: Hall D, Level 1
Improve your ability to adjust treatment when converting from immediate release opioid formulations to extended release/long-acting preparations, as well as your ability to identify risk factors for opioid-induced respiratory depression.
Learning Objectives:
  1. Convert patients from immediate-release to ER/LA opioids as well as from one ER/LA opioid to another.
  2. Identify predisposing risk factors for significant respiratory depression.
Faculty:
  1. Jeffrey Gudin, MD, Director, Pain Management and Palliative Care, Englewood Hospital and Medical CenterEnglewood, NJ (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Test Your Skills in Difficult Cases: Atrial Fibrillation
Room: Floridian Ballroom, Level 3
This session will provide important take away information on the use of anticoagulant therapy in afib patients that is evidence and guideline based. Also included will be approaches to differentiate between rate and rhythm control that can direct appropriate treatment strategies.
Learning Objectives:
  1. Describe current guidelines and clinical evidence regarding the use of anticoagulant therapy in patients with atrial fibrillation (AF).
  2. Differentiate between rate and rhythm control in AF and direct appropriate treatment strategies based on these parameters.
Faculty:
  1. Kent Nilsson, MD, FACC, Assistant Professor of Medicine, Director, Complex Ablations, Athens Regional Medical Center, University of Georgia/Georgia Regents UniversityAthens, GA (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
Room: Hall D, Level 1
Improve your ability to manage adverse reactions with extended release/long-acting opioid formulations and to monitor patient adherence to treatment.
Learning Objectives:
  1. Evaluate and manage adverse effects of ER/LA-opioids.
  2. Differentiate strategies for monitoring patient adherence.
Faculty:
  1. Jeffrey Gudin, MD (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Networking Break
CLOSE  X  
An Algorithmic Approach to Diabetes Management: Insulin-Based Therapy
Room: Floridian Ballroom, Level 3
Sequential insulin strategies recommended by the ADA/EASD will be reviewed and evidence-based insulin regimens will be provided that can be used to initiate treatment that gets type 2 diabetic patient to their A1c goals.
Learning Objectives:
  1. Describe the sequential insulin strategies approach recommended by recent guidelines.
  2. Apply evidence-based insulin strategies to help patients with type 2 diabetes achieve their HbA1C goals.
Faculty:
  1. Javier Morales, MD, Advanced Internal Medicine Group, PC, Advanced Internal Medicine GroupNew Hyde Park, NY, St. Francis Hospital, Advanced Internal Medicine GroupNew Hyde Park, NY (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
Room: Hall D, Level 1
This session will provide important take away strategies for counseling patients and caregivers to ensure appropriate use of extended release/long-acting opioids and recognition of signs of overdose.
Learning Objectives:
  1. Implement counseling strategies to ensure patients know to take ER/LA opioids exactly as prescribed.
  2. Use counseling strategies to explain signs of ER/LA opioid overdose to patients and caregivers.
Faculty:
  1. Michael Brennan, MD, FACP, FASAM, Medical Director, MD, The Pain Center of FairfieldFairfield, CT (Bio)
  2. Jeffrey Gudin, MD (Bio)
  3. Charles Argoff, MD
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
SAFE Opioid Prescribing: Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
Room: Hall D, Level 1
When individualizing your pain management treatment approach, learn how to assess differences in opioid metabolism and potential drug interactions in your patient, and how these factors will impact treatment.
Learning Objectives:
  1. Assess the differences in opioid metabolism and how these impact appropriate ER/LA prescribing.
  2. Identify how opioid-drug interactions influence ER/LA opioid prescribing.
Faculty:
  1. Michael Brennan, MD, FACP, FASAM, Medical Director, MD, The Pain Center of FairfieldFairfield, CT (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
Room: Floridian Ballroom, Level 3
Elderly patients with dementia present the practicing physician with the challenge of managing the psychiatric and behavioral spectrum of this disorder: memory problems, mood disorders, sleep disturbances, apathy, delusions, hallucinations, wandering, and agitation . This session will provide assistance in the differential diagnosis and the selection of appropriate pharmacologic and nonpharmacologic treatments for behavioral problems.
Learning Objectives:
  1. Differentiate the variation in symptoms of the dementing disorders depending upon their etiology.
  2. Apply appropriate pharmacologic therapies for behavioral problems associated with dementia.
  3. Apply appropriate non-pharmacological therapies for agitation with special attention to the environment.
Faculty:
  1. Katherine Galluzzi, DO, CMD, Professor and Chairperson, Department of Geriatric Medicine, Department of Geriatric MedicinePhiladelphia, PA, Director, Comprehensive Care @ PCOM, Philadelphia College of Osteopathic MedicinePhiladelphia, PA, Medical Director, Hospice of Philadelphia, VNA of Greater PhiladelphiaPhiladelphia, PA (Bio)
CLOSE  X  
SAFE Opioid Prescribing: Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
Room: Hall D, Level 1
Improve your understanding of the official prescribing information for available extended release/long-acting opioids, as well as the doses indicated for opioid-tolerant patients.
Learning Objectives:
  1. Differentiate the prescribing information among available ER/LA opioids.
  2. Identify ER/LA opioids and dosages indicated for opioid-tolerant patients only.
Faculty:
  1. Charles Argoff, MD, Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center Albany, NY
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
CLOSE  X  
Medical Brain Game: SAFE Opioid Prescribing Edition
Room: Hall D, Level 1
This session makes use of an engaging quiz show format to reinforce the essential elements in the appropriate use of opioids in pain management.
Learning Objectives:
  1. Compete in this practical, REMS-themed medical knowledge game, sure to provide a fun challenge.
Faculty:
  1. Charles Argoff, MD
  2. Michael Brennan, MD, FACP, FASAM (Bio)
  3. Jeffrey Gudin, MD (Bio)
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesics REMS education requirements issued by the U.S. Food & Drug Administration (FDA).
 
 SAFE Opioid Prescribing | Strategies. Assessment. Fundamentals. Education.
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
3:15PM
 
3:45PM
 
4:15PM
 
4:45PM
 
5:15PM
 
5:45PM
 
7:45 AM-8:45 AM
Obesity in America from the Dietary Counselor and Lifestyle Coach from "The Biggest Loser"
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-11:45 AM
Live Demonstration Orthopedic Exam: See It, Do it
9:45 AM-10:45 AM
Targeting Better Cardiac Outcomes for High-Risk Patients
 
 
 
10:45 AM-11:45 AM
Understanding Dyslipidemia Testing and Screening: Importance of Lipoprotein Particle Analysis
 
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-2:30 PM
SAFE Opioid Prescribing: Evaluation is Essential for Safe and Effective Pain Management Using ER/LA Opioids
1:45 PM-2:45 PM
Engaging e-Patients: How e-Messaging, Personal Health Records, and Patient Activation Can Transform Your Practice
 
 
2:30 PM-3:00 PM
SAFE Opioid Prescribing: Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between
2:45 PM-3:45 PM
Test Your Skills in Difficult Cases: Atrial Fibrillation
3:00 PM-3:45 PM
SAFE Opioid Prescribing: Evidence-Based Tools for Screening for Patients at Risk and Monitoring for Adherence to Prescribed ER/LA Opioids
 
 
3:45 PM-4:00 PM - Networking Break
4:00 PM-4:30 PM
SAFE Opioid Prescribing: Talk to Me: Proven Methods to Counsel Your Patients on ER/LA Opioids and Achieve Positive Outcomes
4:00 PM-5:00 PM
An Algorithmic Approach to Diabetes Management: Insulin-Based Therapy
 
4:30 PM-5:00 PM
SAFE Opioid Prescribing: Everything You Always Wanted to Know About ER/LA-Opioids as a Drug Class
 
5:00 PM-5:30 PM
SAFE Opioid Prescribing: Getting the Most Clinical Insights from Specific ER/LA Product Information Sources
5:00 PM-6:00 PM
Tips for Managing Behavioral Issues in Elderly Patients with Dementia
 
5:30 PM-6:00 PM
Medical Brain Game: SAFE Opioid Prescribing Edition
 
CLOSE  X  
Back to the Future: Yesterday’s Ideas, Today’s Insights, Tomorrow’s Cures
Room: Hall D, Level 1
Learning Objectives:
  1. To explain that there are scientifically promising and immediately implementable medical treatments that are not being adequately developed and clinically tested due to financial considerations.
  2. To name the broad categories of remedies that fall into this realm and to give examples from the world of cancer.
  3. To name some of the challenges that need to be overcome in solving this problem and how patients can drive this agenda.
Faculty:
  1. Vikas Sukhatme, MD, PhD, Victor J. Aresty Professor of Medicine, Harvard Medical SchoolBoston, MA, Chief of the Division of Interdisciplinary Medicine and Biotechnology, Department of Medicine, Beth Israel Deaconess Medical CenterBoston, MA, Chief Academic Officer and Harvard Faculty Dean for Academic, Beth Israel Deaconess Medical CenterBoston, MA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
Room: Floridian Ballroom, Level 3
Improve your recognition of the signs and symptoms of major depressive disorder with differentiation from bipolar disorder. Improve your knowledge in the best practice selection of pharmacologic treatments for patients with uncomplicated depression and somatization.
Learning Objectives:
  1. Recognize the signs and symptoms of major depressive disorder (MDD) and initiate therapy with close monitoring.
  2. Differentiate bipolar disease from symptoms of depression in order to determine appropriate treatment.
  3. Consider actions and side effects of drugs and drug classes when deciding on which treatment to select for patients with psychiatric disorders.
Faculty:
  1. Marius Commodore, MD, Associate Professor of Medicine & Psychiatry, Section of General Internal Medicine, Temple University School of MedicinePhiladelphia, PA (Bio)
CLOSE  X  
Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
Room: Hall D, Level 1
This session will provide guidance on whom to screen for obstructive sleep apnea in your primary care practice, how to screen, interventions and the differences you will encounter between male and female patients with this condition.
Learning Objectives:
  1. Implement practice-based procedures to screen and manage patients at risk for or with evidence of obstructive sleep apnea .
  2. Co-manage patients with OSA and encourage continued monitoring and compliance with CPAP therapy.
Faculty:
  1. Jonathan Lown, MD, Adjunct Faculty, Stony Brook UniversityStony Brook, NY (Bio)
CLOSE  X  
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
Room: Hall D, Level 1
Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis and pulmonary embolism. This session will assist you in identifying high risk medical and hospitalized patients in whom thromboprophylaxis should be initiated and appropriate oral regimens for extended thromboprophylaxis after hospital discharge.
Learning Objectives:
  1. Identify high risk medical and hospitalized patients for whom thromboprophylaxis should be initiated.
  2. Determine appropriate oral regimens for extended thromboprophylaxis after hospital discharge.
Faculty:
  1. Christian Ruff, MD, MPH, Instructor in Medicine, Harvard Medical SchoolBoston, MA, Associate Physician, Cardiovascular Division, Brigham and Women's HospitalBoston, MA (Bio)
CLOSE  X  
Fighting a Growing Epidemic: A Viral Hepatitis Update
Room: Floridian Ballroom, Level 3
This session will provide up-to-date guidelines for screening and evaluating patients with HCV virus infection in the primary care setting. Current best evidence will be presented to guide initiation of antiviral therapy and treatment monitoring for HCV and HBV.
Learning Objectives:
  1. Assess updated guidelines for screening and evaluating patients for HCV in the primary care setting.
  2. Direct antiviral therapy for HCV and HBV using best available evidence.
  3. Monitor patients for antiviral treatment response and toxicities.
Faculty:
  1. Nancy Reau, MD, Associate Professor of Medicine, Medicine, University of Chicago Chicago, IL (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Infectious Diseases Update in Primary Care
Room: Hall D, Level 1
This infectious disease update session provides guidance on applying current clinical guidelines to the diagnosis and treatment of acute bacterial sinusitis, differential diagnosis and management of latent tuberculosis infection, and evidence-based management of genital herpes.
Learning Objectives:
  1. Apply current clinical guidelines to the diagnosis and treatment of acute bacterial sinusitis.
  2. Differentiate the diagnosis of latent tuberculosis infection from that of active tuberculosis.
  3. Apply current evidence and guidelines to the clinical management of genital herpes.
Faculty:
  1. Kalpana Gupta, MD, MPH, Associate Professor of Medicine, Boston University School of MedicineBoston, MA (Bio)
CLOSE  X  
Lipid Management: A Primary Care Perspective
Room: Floridian Ballroom, Level 3
Be up to date on current studies evaluating the benefits of raising HDL in reducing CV risk and how intense treatment should be to reduce residual risk for CHD.
Learning Objectives:
  1. Utilize evidence-based lipoprotein management strategies for non-LDL-C lipid targets
  2. Describe the risk factors, disease spectrum, and appropriate management of familial hypercholesterolemia.
Faculty:
  1. Alan Brown, MD, FACC, FNLA , FAHA, Clinical Associate Professor of Medicine, Stritch School of Medicine, Loyola UniversityChicago, IL, Medical Director, Midwest Heart Specialists at Advocate Healthcare, Midwest Heart Disease Prevention Center, Director, Division of Cardiology, Advocate Lutheran General HospitalPark Ridge, IL (Bio)
CLOSE  X  
Finding Clinical Value in EHR Meaningful Use
Room: Floridian Ballroom, Level 3
Many physicians are warry of the time and resource commitment to implementing an EHR in their practice.This session will provide tangible examples of the value of EHRs and meaningful use in your practice, with suggestions of next steps in their use.
Learning Objectives:
  1. Understand the rationale for and intentions of Meaningful Use.
  2. Identify examples creating value from EHRs and Meaningful Use.
Faculty:
  1. Peter Basch, MD, Medical Director, Ambulatory EHR and Health IT Policy, Medical Director, MedStar Million HeartsWashington DC, DC (Bio)
CLOSE  X  
Caring for the Older Patient - Handling Behavioral Issues
Room: Hall D, Level 1
Learning Objectives:
  1. To learn how to treat behavioral disturbances or psychotic symptoms
  2. Discuss opportunities to integrate a falls assessment and intervention program into a busy primary care practice.
  3. Describe opportunities to integrate members of an interdisciplinary team in the outpatient setting.
Faculty:
  1. Samir Sabbag, MD, Assistant Professor of Clinical Psychiatry, Department of Psychiatry & Behavioral Sceinces, University of Miami Miller School of MedicineMiami, FL (Bio)
CLOSE  X  
Networking Break
CLOSE  X  
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
Room: Floridian Ballroom, Level 3
This session will provide you with actionable information regarding insect pest borne infectious diseases, including the topic of the manifestations of Lyme disease and test interpretation to manage these patients and identifying body lice infestation with patient education regarding treatment and prevention.
Learning Objectives:
  1. Differentially diagnose common tick-borne diseases using symptomology, epidemiologic evidence, and lab tests, and prescribe antibiotic therapy as indicated.
  2. Diagnose and manage clinical manifestations of common pest infestations, including lice, mites, and bed bugs.
Faculty:
  1. Charles Davis, PhD , MD, South Texas Surgical and Spine Hospital (Bio)
CLOSE  X  
Management of the Long-Term Effects of Cancer and Cancer Therapy in Primary Care
Room: Hall D, Level 1
Cardiovascular health is increasingly becoming an issue in long-term cancer survivors, requiring closer attention to its management. Learn how to assess and address cardiovascular risk in cancer survivors.
Learning Objectives:
  1. Explore the evidence regarding cardiovascular disease in survivors of certain types of cancer.
  2. Encourage cancer survivor patients to adopt healthy lifestyles to reduce CV and cancer risk.
  3. Implement screening guidelines for cancer survivors to reduce future cancer risk.
Faculty:
  1. Emily Tonorezos, MPH , MD (Bio)
CLOSE  X  
New Insights into Reducing CV Risk in Patients with Type 2 Diabetes
Room: Floridian Ballroom, Level 3
This session will provide actionable information for implementing current evidence-based guidelines to reduce CVD risk in type 2 diabetes patients and will utilize a case-based approach that addresses CV risk factors such a dyslipidemia and hypertension in these patients.
Learning Objectives:
  1. Identify key factors associated with increased cardiovascular outcomes in patients with type 2 diabetes
  2. Implement current evidence-based guidelines to reduce the risk of CV disease in patients with type 2 diabetes mellitus
Faculty:
  1. JoAnne Foody, MD, FACC, FAHA, Assistant Professor of Medicine, Yale School of MedicineNew Haven, CT, Associate Professor of Medicine, Harvard Medical SchoolBoston, MA, Staff Physician, Brigham and Women's HospitalBoston, MA (Bio)
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
3:15PM
 
3:45PM
 
4:15PM
 
4:45PM
 
5:15PM
 
5:45PM
 
7:45 AM-8:45 AM
Back to the Future: Yesterday’s Ideas, Today’s Insights, Tomorrow’s Cures
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
Obstructive Sleep Apnea: Interventions That Will Help Your Patients Sleep Better
9:45 AM-10:45 AM
Improve Patient Outcomes with Effective Diagnosis and Treatment of Underlying Psychiatric Disorders
 
 
 
10:45 AM-11:45 AM
VTE Prevention: Avoiding the Avoidable in Medical and High-Risk Patients
10:45 AM-11:45 AM
Fighting a Growing Epidemic: A Viral Hepatitis Update
 
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-2:45 PM
Infectious Diseases Update in Primary Care
1:45 PM-2:45 PM
Lipid Management: A Primary Care Perspective
 
 
 
2:45 PM-3:45 PM
Caring for the Older Patient - Handling Behavioral Issues
2:45 PM-3:45 PM
Finding Clinical Value in EHR Meaningful Use
 
 
 
3:45 PM-4:00 PM - Networking Break
4:00 PM-6:00 PM
Management of the Long-Term Effects of Cancer and Cancer Therapy in Primary Care
4:00 PM-5:00 PM
The Problem Pests: Ticks, Mites, Bedbugs, and Lice
 
 
 
5:00 PM-6:00 PM
New Insights into Reducing CV Risk in Patients with Type 2 Diabetes
 
 
 
CLOSE  X  
Mission Control: Medical Excellence
Room: Hall D, Level 1
This year's keynote address will be delivered by Dr. Story Musgrave, physician astronaut, who flew on each of the 5 different NASA Space Shuttles and led the first repair mission to the Hubble Space Telescope. With his broad educational background that includes mathematics, operational analysis, chemistry, literature, and cardiovascular and exercise physiology, Dr. Musgrave will provide his unique perspective on the mission of acheiving clinical success and optimal patient outcomes.
Learning Objectives:
  1. Consider care of all patients as an urgent mission with critical outcomes.
  2. Lead your team to ensure optimal patient outcomes through spirit, ownership, and passion for the mission.
  3. Apply the best practices, procedures, and processes to guarantee that your path to clinical success is the best available.
Faculty:
  1. Story Musgrave, MD , MS, Astronaut, NASA, Innovator, Applied Minds Inc., Professor of Design, Art Center College of DesignPasadena, CA (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Women’s Health Update: Clinical Pearls for Primary Care
Room: Hall D, Level 1
A review of the spectrum of common health concerns in postmenopausal women and their prevention and management.
Learning Objectives:
  1. Weigh the evidence for benefits versus harms when considering hormone replacement therapy for women with menopausal symptoms.
  2. Proactively screen and treat elderly women to prevent falls and fractures.
Faculty:
  1. Kelly Spratt, DO, FACC, FACP, Clinical Associate Professor of Medicine, University of PennsylvaniaPhiladelphia, PA (Bio)
CLOSE  X  
Critical Caveats for Common Medications
Room: Floridian Ballroom, Level 3
Case-based review of side effects and drug interations encountered with commonly used medications including proton pump inhibitors, triptans, antibiotics, anticoagulants, NSAIDs, and antidepressants.
Learning Objectives:
  1. Effectively manage patients who are on statin therapy with respect to potential drug interactions and muscle-related symptoms.
  2. Consider potential adverse effects of proton pump inhibitors, such as impaired absorption of certain nutrients, when prescribing as long-term therapy.
Faculty:
  1. Douglas Paauw, MD, Professor of Medicine, Rothman Family Foundation, Endowed Chair in Patient-Centered Clinical Education, University of Washington School of MedicineSeattle, WA (Bio)
CLOSE  X  
Lung Sounds: A Primer on Pulmonary Auscultation
Room: Hall D, Level 1
This primer on pulmonary auscultation will permit you to identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently, and link them to the scientific and literature validation that supports their clinical relevancy.
Learning Objectives:
  1. Recognize and identify various breath sounds and adventitious lung sounds, including those findings which have been described only recently.
  2. Link literature validation and scientific basis to those sounds and extra-sounds which are clinically relevant.
  3. Establish a clinico-pathologic correlation for sounds and extra-sounds and murmurs.
Faculty:
  1. Salvatore Mangione, MD, Associate Professor of Medicine, Jefferson Medical CollegePhiladelphia, PA (Bio)
CLOSE  X  
End of Life Care
Room: Floridian Ballroom, Level 3
Learning Objectives:
  1. Provide an introduction to the most common dilemmas faced by providers caring for patients at the end-of-life
  2. Understand and learn techniques to integrate advanced care planning discussions for all patients in usual care
  3. Learn to assess decisional-capacity at the end-of-life and the role of surrogate decision-makers
Faculty:
  1. Panagiota Caralis, FACP , MD, JD, Professor of Medicine, University of Miami School of MedicineMiami, FL (Bio)
CLOSE  X  
Networking Break and Additional Opportunities
CLOSE  X  
Nonalcoholic Fatty Liver Disease (NAFLD): Another Obesity-Related Epidemic
Room: Floridian Ballroom, Level 3
Non-alcoholic fatty liver disease is seen in many patients who are overweight or obese, or have diabetes, high cholesterol or high triglycerides. This session will review the spectrum of this condition, risk factors, referral advice, and application of the most current evidence-based recommendations for management.
Learning Objectives:
  1. Identify the risk factors and disease spectrum of non-alcoholic fatty liver disease.
  2. Apply the latest evidence-based recommendations for the management of NAFLD.
  3. Understand the indications for liver biopsy and further investigation.
Faculty:
  1. Samer Gawrieh, MD, ASSOCIATE PROFESSOR OF MEDICINE, MEDICINE/GASTROERNTOEROLOY AND HEPATOLOGY, Indiana University School of MedicineIndianapolis, IN (Bio)
CLOSE  X  
An Algorithmic Approach to Diabetes Management: Combination Non-Insulin Therapy
Room: Hall D, Level 1
Improve your individualization of combination therapy for glycemic control in your diabetic patient that takes into account the enitire patient support structure.
Learning Objectives:
  1. Differentiate among the drug classes’ pros and cons when considering combination non-insulin therapy for type 2 diabetes patients who are not at goal.
  2. Customize combination therapy by taking into account a patient’s support system, health care resources and desire/ability to take an active role in his/her diabetes care.
Faculty:
  1. Richard Pratley, MD, Professor, Sanford Burnham Medical Research InstituteOrlando, FL, Director, Florida Hospital Diabetes InstituteOrlando, FL (Bio)
CLOSE  X  
Prevention of Medical Errors
* This activity meets the criteria of the Florida Board of Registration in Medicine for 1 credit of Prevention of Medical Errors. Please check your individual state licensing board requirements before claiming Prevention of Medical Errors credit. ** pmiCME designates the session; Prevention of Medical Errors, for 1.0 credit of Prevention of Medical Errors.
Learning Objectives:
  1. Identify the most common quality of care errors: diagnostic and performance-related
  2. Create risk management measures to prevent medical errors and increase patient safety
  3. Understand the elements of root cause analysis
Faculty:
  1. Panagiota Caralis, FACP , MD, JD, Professor of Medicine, University of Miami School of MedicineMiami, FL (Bio)
7:45AM
 
8:15AM
 
8:45AM
 
9:15AM
 
9:45AM
 
10:15AM
 
10:45AM
 
11:15AM
 
11:45AM
 
12:15PM
 
12:45PM
 
1:15PM
 
1:45PM
 
2:15PM
 
2:45PM
 
3:15PM
 
7:45 AM-8:45 AM
Mission Control: Medical Excellence
 
 
 
8:45 AM-9:45 AM - Networking Break and Additional Opportunities
 
 
 
9:45 AM-10:45 AM
Women’s Health Update: Clinical Pearls for Primary Care
9:45 AM-10:45 AM
Critical Caveats for Common Medications
 
 
 
10:45 AM-11:45 AM
Lung Sounds: A Primer on Pulmonary Auscultation
10:45 AM-11:45 AM
End of Life Care
 
 
 
11:45 AM-1:45 PM - Networking Break and Additional Opportunities
 
 
 
 
 
 
 
1:45 PM-2:45 PM
An Algorithmic Approach to Diabetes Management: Combination Non-Insulin Therapy
1:45 PM-2:45 PM
Nonalcoholic Fatty Liver Disease (NAFLD): Another Obesity-Related Epidemic
 
 
 
2:45 PM-3:45 PM
Prevention of Medical Errors
 
 
 

Ticketed Events

For 2014, Pri-Med is implementing a new ticketing policy to give all attendees equal opportunity to attend the additional events within the conference. Distribution of all additional opportunity tickets will happen on-site on a first-come, first-served basis at the Ticket Booth. Please check-in early to ensure tickets are available for the additional opportunities you want to participate in.

Ticket Booth Hours
Thursday, February 6: 6:30am–4:30pm
Friday, February 7: 6:45am–2pm
Saturday, February 8: 5:45am–2pm
Sunday, February 9: 6:45am–12:30pm

Morning Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Low T

Lunch Break

CME Educational Symposia

12:00 PM-1:30 PM

Rheumatoid Arthritis

Non-CME Presentation Theater

11:50 AM-12:35 PM

HAE

11:50 AM-12:35 PM

Diabetes

11:50 AM-12:35 PM

Acne

11:50 AM-12:35 PM

Statins

11:50 AM-12:35 PM

Rheum/AS

12:55 PM-1:40 PM

Asthma

12:55 PM-1:40 PM

Atrial Fibrillation / Stroke

12:55 PM-1:40 PM

Obesity

Dinner

Breakfast

CME Educational Symposia

6:00 AM-7:30 AM

Alzheimer’s

Morning Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Diabetes Prevention

Lunch Break

CME Educational Symposia

12:00 PM-1:30 PM

Alzheimer’s

Non-CME Presentation Theater

11:50 AM-12:35 PM

Obesity

11:50 AM-12:35 PM

Diabetes

11:50 AM-12:35 PM

COPD

11:50 AM-12:35 PM

Lipids

12:55 PM-1:40 PM

Gastro

12:55 PM-1:40 PM

Diabetes

12:55 PM-1:40 PM

Pancreatic Insufficiency

12:55 PM-1:40 PM

Depression

Dinner

CME Educational Symposia

6:15 PM-7:45 PM

Alzheimer’s

Morning Break

Non-CME Presentation Theater

8:55 AM-9:40 AM

Alzheimers

8:55 AM-9:40 AM

Women's Health

8:55 AM-9:40 AM

Men's Health

Lunch Break

Non-CME Presentation Theater

11:50 AM-12:35 PM

Dupuytrens Contracture

11:50 AM-12:35 PM

Cardiac Imaging

CLOSE  X  
A Low-Volume Formulation for the Treatment of Hypogonadism
Room: Theater 1
Faculty:
  1. Mitchell Jacobson, MD
CLOSE  X  
RAPID - Rheumatoid Arthritis: A Primary Care Initiative for Improved Diagnosis and Outcomes
Room: Grand Floridian D, Level 3
Learning Objectives:
  1. Identify patients who have early RA by incorporating simple screening tests into daily practice
  2. Employ the squeeze test to assist with diagnosis of RA
  3. Order appropriate laboratory tests when RA is suspected
  4. Appropriately manage infections in patients taking DMARD therapy
  5. Assess and aggressively reduce CVD risk in RA patients
Faculty:
  1. Paul Doghramji, FAAFP , MD, Medical Director of Health Services, Ursinus CollegeCollegeville, PA, Family Physician, Collegeville Family PracticeCollegeville, PA (Bio)
  2. Jeffrey Kaine, MD, Director, Sarasota Arthritis Research CenterSarasota, FL
  3. M. Suzanne Schrandt, JD, Deputy Director, Patient Engagement, Patient-Centered Outcomes Research InstituteWashington, DC
The CME activity is supported by an educational grant from Supported by independent educational grants from Abbvie and Janssen Biotech .
CLOSE  X  
Medical Mystery: A Case of Unexplained Recurrent Abdominal Pain
Room: Theater 4
Faculty:
  1. Mark Scarupa, MD
CLOSE  X  
Advancing Paradigm Changes in Type 2 Diabetes Management
Room: Theater 3
Faculty:
  1. Richard Aguilar, MD
CLOSE  X  
Acne Treatment Guidelines and Patient Case Review
Room: Theater 6
Faculty:
  1. Manju George
CLOSE  X  
LIVALO: EMERGING CLINICAL CONSIDERATIONS AND KEY ATTRIBUTES
Room: Theater 2
This program will consist of a 30-minute presentation about the use of LIVALO (pitavastatin) in adult patients with primary hyperlipidemia or mixed dyslipidemia followed by a 15-minute question and answer session. Program Objectives - Review dyslipidemia management strategies in certain patient populations - Review the clinical efficacy and safety profile of LIVALO - Discuss the role of LIVALO in adult patients with primary hyperlipidemia or mixed dyslipidemia
Faculty:
  1. Michael Cobble, MD
CLOSE  X  
Inflammatory Back Pain Recognition and Diagnosis
Room: Theater 1
Faculty:
  1. Howard Busch, DO, FACR
CLOSE  X  
Therapeutic Advances in the Treatment of Small Airways And Asthma
Room: Theater 1
Faculty:
  1. Mark Stein, M.D., FAAAAI
CLOSE  X  
A Paradigm Shift In The Treatment of Thrombosis
Room: Theater 4
Faculty:
  1. Mark Rumbak, MD (Bio)
CLOSE  X  
A Novel Treatment Option for Chronic Weight Management
Room: Theater 2
CLOSE  X  
Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
Room: Grand Floridian B, Level 3
Learning Objectives:
  1. Describe the pathophysiologic underpinnings of Alzheimer’s disease, including the role of amyloid ß
  2. Identify patients with risk factors and clinical symptoms that suggest a more formal evaluation for Alzheimer’s disease is warranted
  3. Employ new diagnostic criteria for mild cognitive impairment and dementia due to Alzheimer’s disease from the nation Institute on Aging - Alzheimer’s Association
  4. Discuss options for biomarker testing and brain imaging in patients who are being evaluated for Alzheimer’s disease
  5. Evaluate emerging therapeutic approaches that target aberrant amyloid production and deposition in patients with Alzheimer’s disease
Faculty:
  1. Adam Fleisher, MD, MAS, Director of Imaging, Banner Alzheimer's InstitutePhoenix, AZ, Medical Director, Alzheimer's Disease Cooperative StudyPhoenix, AZ, Associate Professor, Department of Neurosciences, University of California, San DiegoSan Diego, CA
  2. Michael Rafii, MD, PhD, Director, Memory Disorders Clinic, University of California, San Diego Perlman Ambulatory Care CenterLa Jolla, CA, Assistant Professor of Neurosciences, University of California, San DiegoSan Diego, CA
  3. Eric Tangalos, MD, FACP, Professor of Medicine, Mayo ClinicRochester, MN
  4. Dennis Selkoe, MD, The Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical SchoolBoston, MA, Co-Director, Center for Neurologic Diseases, Department of Neurology, Brigham and Women's HospitalBoston, MA
The CME activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com..
CLOSE  X  
Diabetes Prevention and Management Panel "Understanding Cardiometabolic Disease"
Room: Theater 3
Faculty:
  1. Graham Reedy, MD
CLOSE  X  
Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
Room: Grand Floridian B, Level 3
Learning Objectives:
  1. Describe the pathophysiologic underpinnings of Alzheimer’s disease, including the role of amyloid ß
  2. Identify patients with risk factors and clinical symptoms that suggest a more formal evaluation for Alzheimer’s disease is warranted
  3. Employ new diagnostic criteria for mild cognitive impairment and dementia due to Alzheimer’s disease from the nation Institute on Aging - Alzheimer’s Association
  4. Discuss options for biomarker testing and brain imaging in patients who are being evaluated for Alzheimer’s disease
  5. Evaluate emerging therapeutic approaches that target aberrant amyloid production and deposition in patients with Alzheimer’s disease
Faculty:
  1. Adam Fleisher, MD, MAS, Director of Imaging, Banner Alzheimer's InstitutePhoenix, AZ, Medical Director, Alzheimer's Disease Cooperative StudyPhoenix, AZ, Associate Professor, Department of Neurosciences, University of California, San DiegoSan Diego, CA
  2. Michael Rafii, MD, PhD, Director, Memory Disorders Clinic, University of California, San Diego Perlman Ambulatory Care CenterLa Jolla, CA, Assistant Professor of Neurosciences, University of California, San DiegoSan Diego, CA
  3. Eric Tangalos, MD, FACP, Professor of Medicine, Mayo ClinicRochester, MN
  4. Dennis Selkoe, MD, The Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical SchoolBoston, MA, Co-Director, Center for Neurologic Diseases, Department of Neurology, Brigham and Women's HospitalBoston, MA
The CME activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com..
CLOSE  X  
Emerging Science of Obesity
Room: Theater 2
Faculty:
  1. Donna Ryan, MD (Bio)
CLOSE  X  
Improving Glycemic Control Through DPP-4 Inhibition: Treatment Considerations for Adult Patients with Type 2 Diabetes
Room: Theater 1
This program will present clinical data for a DPP-4 inhibitor used to improve glycemic control in adult patients with T2DM and its implications for regimen selection and individualization. Data on combination therapy with basal insulin will also be discussed.
Faculty:
  1. James Gavin, MD, PhD, III (Bio)
CLOSE  X  
COPD Care: Insights on Treatment Options An Open Gallery Event
Room: Theater 6
Faculty:
  1. Adam Friedlander, MD , MSc
  2. Richard Powell
CLOSE  X  
The Importance of Treating High Triglycerides
Room: Theater 4
Faculty:
  1. Seth Baum, MD, FACC, FACPM , FAHA , FNLA
CLOSE  X  
Hepatic Encephalopathy: A Clinical Dialogue on a Chronic Complication of Cirrhosis
Room: Theater 3
Hepatic encephalopathy (HE) is a chronic complication of cirrhosis that causes a variety of mental and physical symptoms. HE can occur in up to 45% of patients with cirrhosis. It is a debilitating condition marked by a cycle of remission followed by recurrence that is difficult to break. This program explores a twice-daily therapy for reducing the risk of HE recurrence.
Faculty:
  1. Ilan MD, MSc
CLOSE  X  
The Role the Kidney Plays in the Pathophysiology of Diabetes Type 2 Mellitus
Room: Theater 4
Faculty:
  1. Ellen Hirschman Miller
CLOSE  X  
Understanding the Data - Exocrine Pancreatic Insufficiency
Room: Theater 2
Faculty:
  1. Ravi Kondapalli
CLOSE  X  
Discussion of a Treatment Option for Major Depressive Disorder
Room: Theater 1
Faculty:
  1. Prakash Masand, MD
CLOSE  X  
Updates on the Diagnosis and Management of Alzheimer’s Disease Screening, Imaging, and Emerging Treatment Strategies
Room: Grand Floridian B, Level 3
Learning Objectives:
  1. Describe the pathophysiologic underpinnings of Alzheimer’s disease, including the role of amyloid ß
  2. Identify patients with risk factors and clinical symptoms that suggest a more formal evaluation for Alzheimer’s disease is warranted
  3. Employ new diagnostic criteria for mild cognitive impairment and dementia due to Alzheimer’s disease from the nation Institute on Aging - Alzheimer’s Association
  4. Discuss options for biomarker testing and brain imaging in patients who are being evaluated for Alzheimer’s disease
  5. Evaluate emerging therapeutic approaches that target aberrant amyloid production and deposition in patients with Alzheimer’s disease
Faculty:
  1. Adam Fleisher, MD, MAS, Director of Imaging, Banner Alzheimer's InstitutePhoenix, AZ, Medical Director, Alzheimer's Disease Cooperative StudyPhoenix, AZ, Associate Professor, Department of Neurosciences, University of California, San DiegoSan Diego, CA
  2. Michael Rafii, MD, PhD, Director, Memory Disorders Clinic, University of California, San Diego Perlman Ambulatory Care CenterLa Jolla, CA, Assistant Professor of Neurosciences, University of California, San DiegoSan Diego, CA
  3. Eric Tangalos, MD, FACP, Professor of Medicine, Mayo ClinicRochester, MN
  4. Dennis Selkoe, MD, The Vincent and Stella Coates Professor of Neurologic Diseases, Harvard Medical SchoolBoston, MA, Co-Director, Center for Neurologic Diseases, Department of Neurology, Brigham and Women's HospitalBoston, MA
The CME activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com..
CLOSE  X  
Emerging Trends in Alzheimer’s Disease Management: Namenda™ XR—a Treatment Option for Moderate to Severe Patients
Room: Theater 1
Faculty:
  1. Jeff Gelblum, MD (Bio)
CLOSE  X  
What’s New in the Treatment of VMS
Room: Theater 3
Treatment options have been limited for the millions of women with moderate to severe vasomotor symptoms (VMS) associated with menopause in the United States as, to date, hormone therapy has been the only FDA-approved treatment option for these symptoms. Because many women are unable or unwilling to take hormone therapy, symptoms are often left untreated. During this presentation, a nationally recognized menopause expert and researcher will review the clinical profile for a non-hormonal treatment for moderate to severe VMS associated with menopause.
Faculty:
  1. David Portman, MD
CLOSE  X  
Men’s Health Care Spotlight: The Management and Treatment of Erectile Dysfunction
Room: Theater 2
CLOSE  X  
Dupuytren's Contracture in Adults with a Palpable Cord: Clinical Overview and Treatment Options
Room: Theater 1
Faculty:
  1. Nirav Gupta
CLOSE  X  
Evaluating and Determining Patients for Cardiac Radionuclide Imaging
Room: Theater 2
Faculty:
  1. David Wolinsky, MD, FACC, FASNC

Accreditation

Earn up to 27.25 AMA PRA Category 1 Credits™, 27.25 AAFP Prescribed Credits, or 27.25 AANP contact hours of continuing education.

Primary Care Updates
Track One & Track Two
February 6, 2014
Credits Type Accreditation Statement Designation Statement
8.25 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
8.25 AAFP This Live activity, Primary Care Updates, with a beginning date of 02/06/2014, has been reviewed and is acceptable for up to 8.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
8.25 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 8.25 contact hours of continuing education (which includes 4.125 hours of pharmacology).
Annual Conference
February 7—9, 2014
Credits Type Accreditation Statement Designation Statement
19 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this live educational activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
19 AAFP This Live activity, Pri-Med South Annual Conference – ACP Days, with a beginning date of 02/07/2014, has been reviewed and is acceptable for up to 19.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
19 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 19 contact hours of continuing education (which includes 9.500 hours of pharmacology).

Keynote Speakers

Michael Dansinger, MD (Read Bio)

Tufts Medical Center, Boston, MA

Presenting on:

Vikas Sukhatme, MD, PhD (Read Bio)

Harvard Medical School, Boston, MA
Chief of the Division of Interdisciplinary Medicine and Biotechnology, Department of Medicine
Beth Israel Deaconess Medical Center, Boston, MA
Beth Israel Deaconess Medical Center, Boston, MA

Presenting on:

  • Back to the Future: Yesterday’s Ideas, Today’s Insights, Tomorrow’s Cures
    Saturday (February 08, 2014), 7:45 AM-8:45 AM

Story Musgrave, MD, MS (Read Bio)

NASA,
Applied Minds Inc.,
Art Center College of Design, Pasadena, CA

Presenting on:

Exhibit Hall

Pri-Med Exhibit Hall

Hours
Friday, February 7 8:30am–2:30pm
Saturday, February 8 8:30am–2:30pm
Sunday, February 9 8:30am–2pm

The Pri-Med Exhibit Hall is your chance to learn about and compare over 175 of the health care industry’s latest products, treatments, and technologies in one place.

Exhibit Hall Floor
Spend your time in the Exhibit Hall talking to company representatives, evaluating new options, and making purchasing decisions for your practice—all things you do not have time for in your daily schedule. 

Attendee Badge Information

Please Note: As a Pri-Med registrant, you will receive a badge and an Attendance Scan Card, which will have bar codes programmed with your name, address, and professional discipline. You will scan your bar code at the appropriate stations to obtain CME credit or nursing contact hours.

Scanning your card at an exhibit booth or non-CME activity gives the sponsor permission to use your contact information for future correspondence.

Pri-Med South Mobile App

Exhibit Floor Highlights

Presentation Theaters

Join us for an informative snack break, lunch, or dinner discussion about the latest clinical information as it relates to a specific disease state.

Lunchtime workshops in the Presentation Theaters will focus on ways to boost revenue by adding ancillary products and services to your practice. Come and learn from some of the leading experts in the industry.

Exhibitor List

Company Name Booth Number
A Fashion Hayvin, Inc. 1101
AADP 826
AbbVie 223
Alpha 1 Foundation 1208
Amarin Pharma Inc. 817
American College of Physicians 1108
American Express 1203
Arbor Pharmaceuticals, Inc. 1218
AstraZeneca/BMS Alliance 825
Auxilium Pharmaceuticals, Inc. 1011
Biofilm, Inc. 123
Bio-Oil 917
Boiron 319
Cargill 206
Cell Science Systems/ ALCAT 1216
CryoProbe 315
Daiichi Sankyo, Inc. 505
Diva International Inc. 210
DNA Med Test 1227
Eisai, Inc. 614
e-MDs 113
Figure 1 1012
Forest Pharmaceuticals, Inc. 422
Galderma Laboratories LP 927
Gensco Laboratories 217
HAE: Learn About It, Talk About It 117
Hearing Health, Inc. 502
HOLOGIC, Inc. 122
i-Lipo / Chromogenex 1017
Infinite Therapeutics 1001
JSA Medical Group 202
Kowa Pharmaceuticals 707
Life Extension 1117
Magic Massage Therapy 1102
Mederi Therapeutics, Inc 911
MediTouch EHR / HealthFusion 414
Micro Direct 919
Mobius MGMT Group, LLC 108
National HIV/AIDS Clinicians Consultation Center 107
Neilmed Pharmaceuticals, Inc. 522
Noven Pharmaceuticals Inc 1224
Nutramax Laboratories, Inc. 1018
Otto Trading, Inc. 1200
Premier Medcl Products 104
Pri-Med Solutions Center 1122
Rome Foundation 824
Salix Pharmaceuticals, Inc. 1210
seca Corporation 127
Shire 212
South Florida Vascular Associates 900
Summit Doppler/Wallach Surgical Devices 1222
Take Shape for Life 215
The Gideons International 1100
Together Health 923
Ultimate Creations 1103
Venus Concept 526
Vitamix 1005
Wexford Health Sources 317
Xenna Corp 1004
Company Name Booth Number
A to Z Health 218
AbbVie 1116
AllergiEnd 723
Alzheimers Association 1016
AmazingCharts.com 1023
American Diabetes Association 725
AndaMEDS 527
AspirinWorks by Corgenix 200
Atherotech 1109
Auxilium Pharmaceuticals, Inc. 1026
Bionix 416
Boehringer Ingelheim Pharmaceuticals, Inc. 623
Calmoseptine, Inc. 523
Carlson Laboratories 905
Concentra Primary Care 1009
CryoSurgery, Inc 219
Dermalogix Partners Inc 224
DKB MED 125
Doximity 1019
Elsevier Medical Books 400
Exalenz Bioscience Ltd. 222
Florida Center for Allergy & Asthma Care 318
FRONTRUNNERS BOARD REVIEW 226
Genova Diagnostics, Inc 1022
Grifols USA, Inc. 103
Health Diagnostic Laboratory 1217
Hemosure 106
Hyperion Medical 119
IM HealthScience 822
Janssen Pharmaceuticals, Inc 203
Kareo 801
Laclede Inc 525
Lippincott Williams & Wilkins 101
Maico Diagnostics 402
Medical Device Division of OAPI, Inc. 100
Medstar Laboratory 316
Mission Pharmacal Co 901
MPR 1214
ndd Medical Technologies 1225
New Balance Athletic Shoes/Aravon Shoes 110
Novo Nordisk Inc. 803
Orasure Technologies, Inc. 913
Personna 1010
Pri-Med Recharge Lounge 714
Qiagen, Inc. 1211
RV Marketing 1112
Scarf King 1104
Shader Productions 1204
SHL Telemedicine 504
Spectrum Neurology Group, LLC 111
Take Care Health Services 116
Takeda Pharmaceuticals U.S.A., Inc. 415
The Wall Street Journal 204
U.S. Army Civilian Medical Corps 1215
UltraScope 1115
VitalMD Group Holding, LLC 1000
Western Systems Research 925
WynnPharm Inc. 314
YGM Group, LLC. 1223
Start:  End: 
Expand Expand Instructions Print PrintMap

Travel Arrangements

Meeting Location

Broward County Convention Center
1950 Eisenhower Blvd
Fort Lauderdale, FL 33316-4205
(954) 765-5900

Hotel Accommodations

Important Attendee Notification
Security checkpoints exist at all entrances to the Port Everglades. All attendees will be required to show identification to enter the building (driver’s license or passport).